Biomarkers for acute radiation syndrome: challenges for developing radiation countermeasures following animal rule
نویسندگان
چکیده
منابع مشابه
Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
Acute radiation exposure induces apoptosis of tissues in the hematopoietic, digestive, cutaneous, cardiovascular and nervous systems; extensive apoptosis of these tissues ultimately leads to acute radiation syndrome. A novel strategy for developing radiation countermeasures has been to imitate the genetic mechanisms acquired by radiation-resistant tumors. Two mechanisms that underlie this abili...
متن کاملAcute radiation syndrome and chronic radiation syndrome.
Acute radiation syndrome (ARS) or sickness or poisoning or toxicity is induced after a whole body exposure of men to high doses of radiation between 1-12Gy. First symptoms are from the gastrointestinal system, which together with bone marrow are the most sensitive parts of our body. Chronic radiation syndrome (CRS) may be induced by smaller than 1Gy radiation doses or after a mild form of ARS. ...
متن کاملBiologics as countermeasures for acute radiation syndrome: where are we now?
Despite significant scientific advances toward the development of a safe, nontoxic and effective radiation countermeasure for acute radiation syndrome (ARS) over the past six decades, no drug has been approved by the US FDA. Several biologics are currently under development as radiation countermeasures for ARS, of which three have received FDA Investigational New Drug (IND) status for clinical ...
متن کاملAcute Radiation Syndrome in Humans
INTRODUCTION PATHOPHYSIOLOGY Hematopoietic Syndrome Gastrointestinal Syndrome Neurovascular Syndrome DETERMINANTS OF RADIATION EFFECTS ON HUMANS Lethality Curve Influence of Trauma on LD50 Effect of Clinical Support on the LD50 Dose Effect Curve CLINICAL ASPECTS OF THE US CRITICALITY EXPERIENCE Clinical Course of the Criticality Cases CURRENT TREATMENT OF ACUTE RADIATION SYNDROME Supportive Car...
متن کاملUse of biomarkers for assessing radiation injury and efficacy of countermeasures
Several candidate drugs for acute radiation syndrome (ARS) have been identified that have low toxicity and significant radioprotective and radiomitigative efficacy. Inasmuch as exposing healthy human volunteers to injurious levels of radiation is unethical, development and approval of new radiation countermeasures for ARS are therefore presently based on animal studies and Phase I safety study ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Molecular Diagnostics
سال: 2018
ISSN: 1473-7159,1744-8352
DOI: 10.1080/14737159.2018.1533404